The FDA approved Yuvezzi, a fixed-dose combination eye drop of carbachol and brimonidine tartrate, for the treatment of presbyopia in adult patients.

Glymphatic dysfunction in IIH appears to be an adaptive response to elevated pressure rather than a primary cause of the ...

Flow-diverting stents for carotid-ophthalmic aneurysms show a favorable retinal safety profile with only transient, asymptomatic changes observed.

Despite updated understandings of IOP and glaucoma risk, cutoff values are still a primary influence on treatment ...

The Vision Health Initiative faces a $2 million budget cut in the FY26 appropriations bill, potentially limiting US ocular ...

The ChatGPT o1 Pro can accurately identify glaucoma from visual field and optical coherence tomography data, a study shows.

Patients’ financial resources affect their enrollment in oncology clinical trials to a greater degree than traditional demographic characteristics.

South Carolina’s fast-growing measles outbreak has now reached a major college campus, after health officials confirmed a ...

HealthDay News — Spikes in blood sugar after meals may increase the risk for Alzheimer disease, according to a study ...

With the end of federal health insurance subsidies, President Donald Trump has floated a new plan aimed at changing how ...

HealthDay News — At 11 to 18 months after acute mpox, post-mpox sequelae persist frequently, according to a study published online Jan. 20 in the Annals of Internal Medicine.

Perioperative prostaglandin analog use is not associated with increased risk for pseudophakic cystoid macular edema after cataract surgery.